Identification of prostate cancer modifier pathways using parental strain expression mapping

Inherited genetic risk factors play an important role in cancer. However, other than the Mendelian fashion cancer susceptibility genes found in familial cancer syndromes, little is known about risk modifiers that control individual susceptibility. Here we developed a strategy, parental strain expression mapping, that utilizes the homogeneity of inbred mice and genome-wide mRNA expression analyses to directly identify candidate germ-line modifier genes and pathways underlying phenotypic differences among murine strains exposed to transgenic activation of AKT1. We identified multiple candidate modifier pathways and, specifically, the glycolysis pathway as a candidate negative modulator of AKT1-induced proliferation. In keeping with the findings in the murine models, in multiple human prostate expression data set, we found that enrichment of glycolysis pathways in normal tissues was associated with decreased rates of cancer recurrence after prostatectomy. Together, these data suggest that parental strain expression mapping can directly identify germ-line modifier pathways of relevance to human disease.

[1]  D. Pinkel,et al.  MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma , 2006, Science.

[2]  N. Risch Searching for genetic determinants in the new millennium , 2000, Nature.

[3]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[4]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[6]  W. Hong,et al.  Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[9]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[10]  T. Golub,et al.  mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways , 2004, Nature Medicine.

[11]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[12]  Todd R. Golub,et al.  Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  William Valdar,et al.  Strategies for mapping and cloning quantitative trait genes in rodents , 2005, Nature Reviews Genetics.

[15]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Simon,et al.  Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27 , 2005, Molecular and Cellular Biology.

[17]  W. Zwerschke,et al.  Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. , 2003, The Biochemical journal.

[18]  E. Cuppen Haplotype-based genetics in mice and rats. , 2005, Trends in genetics : TIG.

[19]  A. Darvasi,et al.  Complexities in the genetic dissection of quantitative trait loci. , 2002, Trends in genetics : TIG.

[20]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[21]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[22]  M. Meyerson,et al.  EGFR gene mutations: a call for global x global views of cancer. , 2005, Journal of the National Cancer Institute.

[23]  J. Gray,et al.  The genetics and genomics of cancer , 2003, Nature Genetics.

[24]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[25]  M. Becich,et al.  Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.